entertainment -WSS

entertainment

author：explore 2025-09-28 10:52:37 - browse：47428

A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Coloradans with cystic fibrosis could lose access to Trikafta

WSS

Key Senate panel to consider PBM, drug pricing reform package

Medicare proceeds with plan to claw back hospital funds

Feed a cold, starve a fever? Here’s what science says

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Pennsylvania man bitten on the head by bear during attack in his garage

Sweden knocks USA out of World Cup in penalty kicks

focus

entertainment

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Cancer drug shortages should be causing more outrage

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Wildfire smoke exposes gaps in outdoor worker protections

Slovenia has suffered its worst

Medical leaders decry Supreme Court decision on affirmative action

Lung cancer screening guidelines updated for cigarette smokers

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare must police algorithms in Medicare Advantage, Dems say

focus

Infant mortality in U.S. rose last year for first time in decades: CDC

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Paxlovid rebound happens. Why and to whom are still a mystery

Travis Kelce and the trap of celebrity vaccine endorsements

Election results set back Medicaid expansion plans

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

entertainment

focus

focus

entertainment